Northfield Labs files for bankruptcy

2 June 2009

USA-based Northfield Laboratories has filed a voluntary petition for relief under Chapter 11 of the Bankruptcy Code in the Bankruptcy Court  for the District of Delaware.

The filing was made to facilitate the company's previously-announced  plan to wind down its business operations and carry out an orderly  disposition of its assets. The decision to file was made after an  exhaustive review of alternative options and is seen as the most  favorable means for the firm to continue its wind-down process and  liquidate its remaining assets for the benefit of its creditors and  other interested parties.

The company expects to file with the bankruptcy court a liquidating plan  and related disclosure statement. Northfield says that it will seek  approval of the Plan as expeditiously as practicable pursuant to  relevant notice requirements, the Bankruptcy Code and applicable law and  procedures.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight